FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS
$1,046,113N01FY2022DANIH
Albany Molecular Research, Inc., Albany NY
Investigators
Abstract
This study is part of the NIHâs Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.â Drug Manufacturing and Formulation Program; FEASIBILITY STUDIES; CLINICAL TRIAL READINESS; Good Manufacturing Practice; CLINICAL TRIAL MATERIALS
View original record on NIH RePORTER →